Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Integrated proteogenomic characterization of urothelial carcinoma of the bladder

3 Jun 2022

Abstract excerpt

BACKGROUND: Urothelial carcinoma (UC) is the most common pathological type of bladder cancer, a malignant tumor. However, an integrated multi-omics analysis of the Chinese UC patient cohort is lacking. METHODS: We performed an integrated multi-omics analysis, including whole-exome sequencing, RNA-seq, proteomic, and phosphoproteomic analysis of 116 Chinese UC patients, comprising 45 non-muscle-invasive bladder...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bladder and Urothelial Cancer Treatments
Share to Ferroptosis and cancer prognosis
Share to Urinary and Genital Oncology Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35659036
DOI: 10.1186/s13045-022-01291-7

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Integrated proteogenomic characterization of urothelial carcinoma of the bladderPMID 35659036Read ↗

Proteogenomics of different urothelial bladder cancer stages reveals distinct molecular features for papillary cancer and carcinoma in situSemantic proximity Read ↗

Identification of potential therapeutic targets in urothelial bladder carcinoma of Chinese population by targeted next-generation sequencing.Semantic proximity Read ↗

Molecular Landscape of Bladder Cancer: Key Genes, Transcription Factors, and Drug InteractionsSemantic proximity Read ↗

Molecular targets in urothelial cancer: detection, treatment, and animal models of bladder cancerSemantic proximity Read ↗

Extracellular matrix-related genes play an important role in the progression of NMIBC to MIBC: a bioinformatics analysis studySemantic proximity Read ↗

Multi-Omics Analysis Identifies the Heterogeneity and Prognosis in Bladder CancerSemantic proximity Read ↗

Integrative multi-omics study identifies sex-specific molecular signatures and immune modulation in bladder cancerSemantic proximity Read ↗

Identification and Validation of Hub Genes Associated with Bladder Cancer by Integrated Bioinformatics and Experimental AssaysSemantic proximity Read ↗

Multi-omics Perspective on the Tumor Microenvironment based on PD-L1 and CD8 T-Cell Infiltration in Urothelial CancerSemantic proximity Read ↗

Identification of key candidate genes and biological pathways in bladder cancerSemantic proximity Read ↗

Comprehensive Genomic Characterization Between Urothelial Carcinoma Subtypes/Divergent Differentiation (S/DD) and Pure Urothelial Carcinoma Using a Large-Scale Japanese Genomic Panel Dataset.Semantic proximity Read ↗

Comprehensive genomic profiling of upper tract urothelial carcinoma and urothelial carcinoma of the bladder identifies distinct molecular characterizations with potential implications for targeted therapy & immunotherapySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.